XERIS BIOPHARMA HOLDINGS, INC. Extinguishment of Debt, Amount
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Extinguishment of Debt, Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Debt
us-gaap:ExtinguishmentOfDebtAmount · last filed 2026-03-02
- XERIS BIOPHARMA HOLDINGS, INC. extinguishment of debt, amount for the quarter ending 2023-12-31 was $0.00.
- XERIS BIOPHARMA HOLDINGS, INC. extinguishment of debt, amount for the quarter ending 2022-12-31 was $0.00.
- XERIS BIOPHARMA HOLDINGS, INC. extinguishment of debt, amount for fiscal 2025 was $0.00.
- XERIS BIOPHARMA HOLDINGS, INC. extinguishment of debt, amount for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- XERIS BIOPHARMA HOLDINGS, INC. extinguishment of debt, amount for fiscal 2023 was $31.98M.
- XERIS BIOPHARMA HOLDINGS, INC. extinguishment of debt, amount for fiscal 2022 was $0.00.
| Period end | Extinguishment of Debt, Amount 3 month | Extinguishment of Debt, Amount 9 month | Extinguishment of Debt, Amount 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-02 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $31.98M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $31.98M 10-Q · filed 2023-11-09 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |